As highly pathogenic H5N1 avian influenza continues to spread in the U.S., posing serious threats to dairy and poultry farms, ...

This would maximize sensitivity and use smaller test samples. This study proposed development of a biosensor consisting of polymeric nanopatterned immobilized anti-Her-2 antibodies. Tests were carried ...

Scientists at Oak Ridge National Laboratory have developed a first-ever method of detecting ribonucleic acid, or RNA, inside ...

Biolinq has raised $100 million in venture capital financing to help complete the development of its wearable glucose ...

The study defines biosensors as analytical devices that convert biological reactions into measurable signals, such as changes ...

The Biophotonics Market, long associated with healthcare diagnostics and advanced imaging, is undergoing a transformative ...

The approach streamlines traditional methods used to verify gene expression in modified plants and can better detect plant physiology related to disease or nutrient stress, accelerating the ...

The global biosensors market is set for substantial growth, with a projected increase in market value from US$ 32.14 billion in 2024 to US$ 75.84 billion by 2033, reflecting a compound annual growth ...

SAN DIEGO – Biolinq, a healthcare technology company of biosensors, has received a $100 million Series C financing led by Alpha Wave Ventures ...

Biosensors market in 2025 is driven by advanced healthcare applications, dominated by oxidoreductase enzymes and non-wearable ...

The Series C funding supports Biolinq’s transition from development stage to commercial readiness following US pivotal trial ...

LifeSignals introduces UbiqVue Holter System in partnership with UltraLinQ at Heart Rhythm 2025: Milpitas, California Wednesday, April 23, 2025, 12:00 Hrs [IST] LifeSignals, Inc., ...